We found that not only is YBX1 upregulated or mutated across a broad spectrum of cancers (Supplementary Fig. 2), but its transcript levels (Fig. 8, left panel) are also significantly higher across colorectal adenocarcinoma (COAD) tumors compared to normal tissue counterparts. This evidence concerns the gene YBX1 and colon adenocarcinoma.